R. van Leeuwen

Latest

• Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
• A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients